Silicon Laboratories (NASDAQ:SLAB) Announces Earnings Results, Beats Estimates By $0.07 EPS

Silicon Laboratories (NASDAQ:SLAB) announced its quarterly earnings data on Monday. The semiconductor company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.07, Briefing.com reports. Silicon Laboratories had a negative net margin of 36.53% and a negative return on equity of 9.13%. The firm had revenue of $166.00 million during the quarter, compared to analysts’ expectations of $165.50 million. During the same quarter last year, the business earned $0.48 earnings per share. The business’s revenue for the quarter was down 18.5% compared to the same quarter last year. Silicon Laboratories updated its Q4 guidance to ($0.21)-($0.01) EPS and its Q4 2024 guidance to -0.210–0.010 EPS.

Silicon Laboratories Trading Down 2.1 %

Silicon Laboratories stock traded down $2.21 on Tuesday, reaching $102.53. 115,830 shares of the stock were exchanged, compared to its average volume of 293,922. The stock has a market cap of $3.31 billion, a PE ratio of -14.84 and a beta of 1.20. Silicon Laboratories has a twelve month low of $90.65 and a twelve month high of $154.91. The firm has a fifty day moving average price of $112.84 and a two-hundred day moving average price of $115.65.

Insider Transactions at Silicon Laboratories

In other news, SVP Brandon Tolany sold 845 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total transaction of $97,175.00. Following the sale, the senior vice president now owns 43,615 shares in the company, valued at approximately $5,015,725. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.72% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

SLAB has been the topic of a number of recent analyst reports. Barclays reduced their price target on Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Needham & Company LLC restated a “buy” rating and issued a $150.00 target price on shares of Silicon Laboratories in a report on Thursday, July 25th. StockNews.com raised shares of Silicon Laboratories to a “sell” rating in a research report on Wednesday, October 30th. Finally, KeyCorp lowered their target price on Silicon Laboratories from $150.00 to $115.00 and set an “overweight” rating for the company in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $130.00.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.